CBD trial to treat hallucinations in Parkinson’s disease

Researchers across the UK are trialling a range of cannabis extracts to treat conditions from pain and asthma to brain cancer.

Charles Ogilvie-Forbes is taking part in a study at King’s College Hospital, London, using CBD to treat the hallucinations he experiences due to his Parkinson’s disease.

Filming and graphics: Julius Peacock

Edited: Rachael Buchanan

Source link

View More CBD trial to treat hallucinations in Parkinson’s disease

BDR Pharma receives DGCI nod for its generic drug BIAPENEM, Health News, ET HealthWorld

Mumbai: Pharmaceutical company BDR Pharma launched generic drug BIAPENEM which can be used to treat intra-abdominal infections, lower respiratory infections, or complicated urinary tract infections. BIAPENEM, which will be marketed under the brand name BIAPEN, will be an addition to BDP Pharma’s critical care segment.

BDR Pharma became the first to identify, develop and conduct clinical studies of the drug in conjunction with some of the leading players in the critical care segment who co-sponsored these studies. First approval granted by DCGI (Drug Controller General of India) also went to BDR pharma.
Speaking about the launch of an affordable drug to treat all kinds of infections under the company’s name, Raheel Shah, Director – Business Development, BDR Pharmaceuticals, said, “Further encasing our high standards, the launch of BIAPEN is a welcome addition to the existing range of antibiotics. This drug will cover a broad spectrum of almost every infection and will be a great boon to the medical fraternity and patients. Firmly following the path of accessible and affordable care, we have categorically decided to market this wonder product and we will make arrangements to supply the product to the co-sponsors who will also market it under their brand name.

View More BDR Pharma receives DGCI nod for its generic drug BIAPENEM, Health News, ET HealthWorld